Dermira, Inc., a prominent biopharmaceutical company headquartered in the United States, focuses on developing innovative therapies for dermatological conditions. Founded in 2010, Dermira has made significant strides in the industry, particularly in the treatment of acne and other skin disorders. The company’s core products, including its flagship treatment for acne, are distinguished by their unique formulations and targeted delivery mechanisms, setting them apart in a competitive market. Dermira has established a strong market position, recognised for its commitment to advancing dermatological care through research and development. With a dedicated operational presence across major regions in the US, Dermira continues to drive innovation, aiming to improve the quality of life for patients suffering from skin conditions.
How does Dermira, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Dermira, Inc.'s score of 44 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Dermira, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Eli Lilly and Company, which influences its climate commitments and emissions reporting. As such, any relevant emissions data or reduction targets would be inherited from Eli Lilly and Company. Eli Lilly and Company has made significant strides in sustainability, including commitments to reduce its carbon footprint. However, specific reduction targets or achievements for Dermira, Inc. are not detailed in the available information. The company does not currently have any documented reduction initiatives or climate pledges. As a subsidiary, Dermira's climate strategy may align with Eli Lilly's broader sustainability goals, which include initiatives under frameworks such as the Carbon Disclosure Project (CDP) and RE100. These initiatives aim to enhance transparency and accountability in corporate climate action, although specific metrics for Dermira are not provided. In summary, while Dermira, Inc. does not have its own emissions data or reduction targets, it is positioned within a corporate family that prioritises climate commitments through its parent company, Eli Lilly and Company.
Access structured emissions data, company-specific emission factors, and source documents
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 502,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 1,310,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 200,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Dermira, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.